SKF-86002 dihydrochloride is an orally active p38 MAPK inhibitor with anti-inflammatory and anti-arthritic activities, used in pain relief research; it inhibits LPS-stimulated production of IL-1 and TNF-α in human monocytes and suppresses lipoxygenase- and cyclooxygenase-mediated arachidonic acid metabolism.